Back to results
US 2021/0330797 A1Published application
Stable cannabinoid formulations
AssigneeRadius Pharmaceuticals, Inc.
InventorsKiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
Life of this patent
Estimating the term…
Abstract
The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
Claims17
1-27. (canceled)
An oral composition consisting of:
- 10 to 17% w/w cannabidiol (CBD);
- 60 to 85% w/w sesame oil;
- 5 to 15% w/w ethanol;
- a sweetener;
- a flavoring agent, and
- optionally a preservative,
- wherein the CBD has a purity of greater than 98% w/w, and wherein the composition is a liquid composition for oral administration.
4 more elements
Dependencies are inferred from the claim text.